Discover
CPIX
Cumberland Pharmaceuticals Inc.
7.13
2 x 4.97
2 x 8.32
bid
ask
+
0.65
10.03%
2 @ 07:21 AM
7.25 +0.12 (1.68%)
| Ytd | 79.15% | |
| 1y | 104.30% |
6.44
day range
7.21
1.85
52 week range
7.21
| Open | 6.57 | Prev Close | 6.48 | Low | 6.44 | High | 7.21 | Mkt Cap | 106.83M |
| Vol | 67.61K | Avg Vol | 998.24K | EPS | -0.49 | P/E | N/A | Forward P/E | 16.07 |
| Beta | 0.22 | Short Ratio | 0.92 | Inst. Own | 14.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 5.27 | 200-d Avg | 3.84 | 1yr Est | 8.50 |
| Income Statement | |||
| Total Revenue | 9.13M | ||
| Revenues (USD) | 9.13M | ||
| Cost of Revenue | 1.93M | ||
| Gross Profit | 7.20M | ||
| Operating Expenses | 10.33M | ||
| Research and Development Expense | 1.46M | ||
| Selling, General and Administrative Expense | 7.62M | ||
| Operating Income | -3.13M | ||
| Interest Expense | 85.84K | ||
| Income Tax Expense | 3.87K | ||
| Net Income | -3.29M | ||
| Net Income Common Stock | -3.29M | ||
| Net Income Common Stock (USD) | -3.29M | ||
| Consolidated Income | -3.29M | ||
| Net Income to Non-Controlling Interests | 2.59K | ||
| Earnings per Basic Share | -0.22 | ||
| Earnings per Basic Share (USD) | -0.22 | ||
| Earnings per Diluted Share | -0.22 | ||
| Earning Before Interest & Taxes (EBIT) | -3.20M | ||
| Earning Before Interest & Taxes (USD) | -3.20M | ||
| Weighted Average Shares | 14.96M | ||
| Weighted Average Shares Diluted | 14.96M | ||
| Balance Sheet | |||
| Cash and Equivalents | 11.01M | ||
| Cash and Equivalents (USD) | 11.01M | ||
| Investments | 3.84M | ||
| Investments Non-Current | 3.84M | ||
| Trade and Non-Trade Receivables | 14.26M | ||
| Current Assets | 32.79M | ||
| Property, Plant & Equipment Net | 7.86M | ||
| Total Assets | 71.00M | ||
| Debt Current | 4.97M | ||
| Total Debt | 14.56M | ||
| Current Liabilities | 34.49M | ||
| Debt Non-Current | 9.58M | ||
| Total Liabilities | 49.69M | ||
| Accumulated Retained Earnings (Deficit) | -30.09M | ||
| Shareholders Equity | 21.64M | ||
| Shareholders Equity (USD) | 21.64M | ||
| Assets Non-Current | 38.21M | ||
| Total Debt (USD) | 14.56M | ||
| Goodwill and Intangible Assets | 13.71M | ||
| Inventory | 15.33M | ||
| Liabilities Non-Current | 15.20M | ||
| Trade and Non-Trade Payables | 16.54M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.56M | ||
| Net Cash Flow from Financing | -763.30K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -437.45K | ||
| Capital Expenditure | -19.15K | ||
| Issuance (Purchase) of Equity Shares | -61.00K | ||
| Net Cash Flow from Investing | -61.17K | ||
| Net Cash Flow from Operations | 387.03K | ||
| Share Based Compensation | 106.84K | ||